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This article provides ﬂow cytometry information regarding levels
of expression for hematopoietic stem cell markers CD34 and
CD133 obtained simultaneously of the bone marrow and periph-
eral blood from recipients of allogeneic and autologous transplants
of PB hematoprogenitors for treating hematological malignancies
and who were clinically healthy after Z100 days following the
procedure. CD34 and CD133 expression is compared regarding
type of transplant (autologous vs. allogeneic) and sample cell
source (bone marrow vs. peripheral blood). Patients were condi-
tioned with a reduced-intensity conditioning regimen. Also shown
is the ﬂow cytometry analysis of mononuclear cell and lymphocyte
populations in the peripheral blood of both types of recipients, as
well as the characterization of immune cells, including T lym-
phocyte antigenic make up markers CD3, CD4 and CD8, B lym-
phocytes and NK cells, including total NK, bright and dim subtypes
in the peripheral blood of both types of recipients. For further
information and discussion regarding interpretation and meaning
of post-transplant ﬂow cytometry analysis, please refer to thevier Inc. This is an open access article under the CC BY license
/j.bcmd.2016.03.001
tología, Ediﬁcio “Dr. Rodrigo Barragán”, 2° piso, Hospital Universitario
os S/N, Colonia Mitras Centro, Monterrey, Nuevo León, México, C.P. 64460.
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J.C. Jaime-Pérez et al. / Data in Brief 7 (2016) 1151–11551152article “Assessment of immune reconstitution status in recipients
of a successful hematopoietic stem cell transplant from peripheral
blood after reduced intensity conditioning” [1].
& 2016 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations tableubject area Immunology
ore speciﬁc subject area Transplantation hematology
ype of data Figures
ow data was acquired Flow cytometry
ata format Analyzed
xperimental factors Mononuclear cells were suspended in PBS with bovine serum albumin
and sodium azide in round-bottom tubes and incubated in the dark.
xperimental features Hematoprogenitor and immune mononuclear cells were stained with
pertinent ﬂuorochrome-marked antibodies, then analyzed by ﬂow cytometry.
ata source location Universidad Autónoma de Nuevo León, Monterrey, México
ata accessibility Data is with this article.D
Value of the data Flow cytometry data of bone marrow and peripheral blood of hematology patients who received a
stem cell transplant provides a precise assessment of immune status after grafting is complete.
 This is the ﬁrst report of the correlation between CD34þ and CD133þ hematoprogenitors in bone
marrow and peripheral blood after hematopoietic grafting.
 The data provide an experimental guide to further deﬁne post-transplant reconstitution dynamics
in humans through correlative studies.1. Data
Here, we exemplify the application of CD34/CD133 antigenic make-up analysis in mononuclear cells
after hematopoietic stem cell transplantation (HSCT) by ﬂow cytometry, comparing between type of
transplant, autologous (Auto) vs. allogeneic (Allo), and cell source, bone marrow (BM) vs. peripheral blood
(PB). Figure panels depicting the median and interquartile ranges (25,75) of the percentage values of
different hematoprogenitor populations expressing the characteristic markers CD34 and CD133 are
shown (Fig. 1). To assess their individual contribution to immune cell composition in PB according to
transplant type, T (Fig. 2) NK (Fig. 3) and B (Fig. 4) lymphocytes were studied. Data depicting the median
values and interquartile ranges are presented, comparing the ratio of the different cell components.2. Experimental design, materials and methods
2.1. Cell count and sample preparation for staining
To analyze the data of each peripheral blood sample, a complete blood count was performed with
a Sysmex XS-1000i (Lincolnshire, IL, USA). For antibody staining, 1106 WBC were suspended in a
total volume of 100 μL containing phosphate-buffered saline (PBS), (Miltenyi Biotec) with 0.5% BSA
Fig. 2. The main populations analyzed were A. Total lymphocytes, B. CD4þT-lymphocytes and C. CD8þT-lymphocytes.
Fig. 1. A. CD34þ/CD133 , B. CD34/CD133 , and C. CD133þ/CD34þcells in the bone marrow compartment from allogeneic
(Allo) transplant recipients compared to the rest of the compartments and transplants (po0.001, po0.0001 and po0.001
respectively). D. Values of CD133þ/CD34 cells were similar among groups with no statistical signiﬁcance. Kruskal–Wallis test
was used to compare the groups, with Tukeys post-hoc testnnnpo0.001.
Fig. 3. A. Natural Killer (NK) cells with their respective subsets B. CD56-dim and C. CD56-bright.
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(BD Biosciences).2.2. Antibody panel
We consulted several panels used in relevant literature for sample acquisition [2], ﬂow cytometry
panels in heterogeneous blood samples [3–5] and recent publications of hematoprogenitor cells [6–8]. For
Fig. 4. A. Monocytes and B. B-lymphocytes, (Mann U Whitney test was performed for comparisons, npo0.05).
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anti-CD133 PE (clone 293C3, Miltenyi Biotechnology) were used. To identify mononuclear immune cells
in PB the following panel was employed: anti-CD3 PerCP (clone UCHT1, DAKO), anti-CD4 V450 (clone
RPA-T4, BD Biosciences), anti-CD8 FITC (clone SK1, BD Biosciences), anti-CD19 APC-H7 (clone SJ25-C1, BD
Biosciences), anti-CD45-V500 (clone 2D1, BD Biosciences), anti-CD45 FITC (clone 2D1, BD Biosciences) and
anti-CD56 PE (clone MY31, BD Biosciences). After staining, samples were incubated for 15 min in the dark.2.3. RBC lysing and sample preparation before FACS analysis
The samples were prepared as previously described [9]. After incubation cells were suspended
with 2.0 mL of a 1/10 dilution FACSLysing solution (BD Biosciences) and incubated in the dark for
10 min at room temperature. Cells were centrifuged at 540 gx5 min, the supernatant was discarded
using Pasteur pipettes and the cell pellet suspended in 50 μL of buffer solution. Cells were then
washed with 2.0 mL of PBS containing 0.5% BSA and 0.09% sodium azide, vortexed, and centrifuged at
540 g x 5 min. Finally, the supernatant was discarded and the cells suspended in 200 μL of PBS
containing 0.5% BSA. Cells were kept at 4 °C before analysis.2.4. Determination of population by ﬂow cytometry analysis
Dead cells and debris were discarded by using Forward scatter/Side scatter (FSc/SSc) exclusion in
the sample dotplots; the main location of lymphocytes and monocytes was considered for the gating
strategy. Doublets were excluded by double forward (FSC-A and FSC-H) and side scatter (SSC-A and
SSC-H), prior to gating the relevant sub populations [10]. The methodology to gate cell percentages
was based on previous experience in the laboratory following relevant references regarding hema-
toprogenitor cell [11], and mononuclear [12–14] cell gating. The populations were deemed as follows:
Hematoprogenitors as CD34þ , CD133þor CD34þ/CD133þ (Fig. 1). Lymphocytes and monocytes
being CD45þ . Granulocytes were excluded by size and location in SSc vs. CD45. Total T cells being the
CD45þ/ CD3þpopulation; from these cells the proportions of CD4 and CD8þcells were determined
(Fig. 2). NK cells were deemed as CD45þ/ CD3-/CD56þ , their dim and bright subpopulations were
gated according to the density of expression of CD56 (Fig. 3). B-Lymphocytes were analyzed through
CD3/CD56/CD19þexpression (Fig. 4).
Blank samples and FMOs (Fluorescence minus one) were used to determine the location of the
gating in both, mononuclear and hematoprogenitor cell locations. FMO controls consist of all staining
except one, and is used to determine proper electronic gating [15,16]. All samples were analyzed in a
FACSCanto II ﬂow cytometer (BD Biosciences). The data was collected and analyzed using SPSS v.20
and Prism software.
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